| | 1236699-92-5 Basic information More.. |
| Product Name: | AS703026 | | Synonyms: | AS703026;100330;CS-2173;CS-397;PIMASERTIB; MSC1936369B; AS-703026; AS 703026; PIMASERTIB; MSC1936369B; AS-703026; AS 703026;MSC1936369B;PIMASERTIB;N-[(2S)-2,3-Dihydroxypropyl]-3-[(2-fluoro-4-iodophenyl)amino]-4-pyridinecarboxamide;(S)-N-(2,3-dihydroxypropyl)-3-(2-fluoro-4-iodophenylaMino)isonicotinaMide | | CAS: | 1236699-92-5 | | MF: | C15H15FIN3O3 | | MW: | 431.2 | | EINECS: | | | Mol File: | 1236699-92-5.mol |  |
Use
AS703026 is a novel, selective, orally bioavailable MEK1/2 inhibitor, in human multiple myeloma (MM). AS703026 induces pleiotropic anti-myeloma activity in vitro and in vivo. MEK inhibitors are useful in the treatment of hyperproliferative diseases, such as cancer, restenosis and inflammation.
- Pimasertib
-
- $56.00
- 2026-06-02
- CAS:1236699-92-5
- Purity: 99.57%
- Supply Ability: 10g
- AS703026
-
- $1.10
- 2025-11-18
- CAS:1236699-92-5
- Min. Order: 1g
- Purity: 99.00%
- Supply Ability: 100 Tons Min
- AS703026
-
- $20.00
- 2019-07-06
- CAS: 1236699-92-5
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 20kg
|
|
1236699-92-5
Recommend Suppliers |
|